You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Moodys
Dow
Harvard Business School

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Litigation Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)

Docket   Start Trial Date Filed 2018-06-05
Court District Court, D. Delaware Date Terminated 2018-08-23
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ASTELLAS IRELAND CO., LTD.; ASTELLAS PHARMA EUROPE LTD.; ASTELLAS PHARMA INC.; ASTELLAS PHARMA U.S., INC.; CIPLA LIMITED
Patents 6,017,927
Attorneys Arthur G. Connolly , III; Derek James Fahnestock; Jack B. Blumenfeld; Steven J. Moore
Firms Connolly Gallagher LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Astellas Pharma Inc. v. Cipla Limited
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint an action for patent infringement of United States Patent No. 6,017,927 (“the ’927 patent”), arising under…BACKGROUND A. The ’927 Patent 15. The United States Patent and Trademark Office duly and…correct copy of the ’927 patent is attached as Exhibit A. 16. The ’927 patent claims, inter alia…927 patent. 22. AICL and APEL are exclusive licensees of rights under the ’927 patent. …#39;927 Patent. 35. On information and belief, Cipla was aware of the ‘927 patent and its External link to document
0000-00-00 14 Order relating to United States Patent No. 6,017,927 ("the ' 927 patent"); WHEREAS…927 patent to a Paragraph III certification pursuant to which it agrees that the '927 patent, plus…earlier than the expiration date of the '927 patent, including any extensions and/or additional periods… III certification with respect to the '927 patent, the parties have resolved this action; …2018 23 August 2018 1:18-cv-00844 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 15 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (Attachments: # 1 …2018 23 August 2018 1:18-cv-00844 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
Moodys
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.